Oppilotech Ltd, a biopharmaceutical company founded to develop safe, first-in-class, antibacterial therapies, announced it has been selected for funding by Innovate UK – the UK’s innovation agency.

Stronger strategic investments for further sustainable growth.

New molecular strategy enriches multiple disease-related rare genetic DNA variants with high accuracy in a single assay to enable personalized diagnosis and treatments.

The Uniqsis PhotoSyn™ is a new high-power LED light unit enabling scalable flow photochemistry reactions yielding from milligrams to 100’s of grams per day.

Porvair Sciences has collaborated with Persomics Inc. (Waltham, MA, USA) to develop and supply ANSI/SLAS format Arrays as an OEM product for their ImagineArray™ platform.

Boyds was established 13 years ago, and now employs 10 members of staff working out of its offices in Cheshire and Cambridgeshire.

Synpromics Ltd, the leader in gene control, announces a partnership with Lonza Pharma & Biotech to further develop its inducible promoter system and improve manufacturing of biopharmaceuticals. The 18-month project has been made possible through the award of a £235,000 grant, part of the medicines manufacturing competition from Innovate UK.

Technology will be used to progress Fusion’s pipeline of alpha therapeutics for the treatment of cancers.

Test will expand the range of diagnostic options available to guide treatment of Plasmodium vivax.

Posters by early adopters demonstrate accurate, fast, cost-effective and flexible diagnosis of syndromic infections and other diseases in unique and versatile Sample to Insight workflows.